Community/Retail

Over the past decade we have seen a significant rise in opiate use and abuse, unfortunately, we have seen a paralleled rise in babies born addicted to opiates.

AstraZeneca today announced that MedImmune has entered into a license agreement and collaboration with Inovio Pharmaceuticals, a biotechnology company developing DNA-based immunotherapies.

AkzoNobel has won a coveted Red Dot Award for the digital version of its 2014 annual report.

In recognition of the third anniversary of EpiPen4Schools, Mylan, the marketer and distributor of EpiPen® Auto-Injector, has announced the program will continue through the 2015/2016 school year.

Shire today launches the second annual Excellence in ADHD Patient Group Awards celebrating outstanding work by patient advocacy organisations that aim to improve the lives of people with ADHD.

CVS Health Research Institute experts have encouraged the cardiology community to review and reconsider current treatment guidelines for the management of high cholesterol.

The FDA is alerting health care professionals about serious adverse effects reported with implantable left ventricular assist devices (LVADs).

Hospitals with higher admission rates for chest pain have lower rates of acute myocardial infarction (AMI) and death.

Cindy Lu, who is beginning her fourth year in the Doctor of Pharmacy program at Manchester University, was 1 of only 8 pharmacy students in the nation chosen as a Paul Ambrose Scholar.

Mylan has launched a generic version of AstraZeneca's proton pump inhibitor (PPI) Nexium.

School vaccination requirements have traditionally helped boost immunization rates, but in most states, parents may seek exemptions for religious, medical, or philosophical reasons.

Pharmacists have many opportunities for collaborating with nurse practitioners and physician assistants on managing chronic and acute conditions commonly seen in the retail health practice setting.

Michael Evans, Geisinger Health System, Receives Top Honor in Pharmacy; Industry Leaders Recognized at Sixth Annual Next-Generation Pharmacist Awards Gala

Pharmacy Times and Parata Systems honored pharmacists at the 2015 Next-Generation Pharmacist® Awards gala at Universal Studios in Orlando, Florida, on August 6.

Heart Hospital of New Mexico at Lovelace Medical Center has received the American Heart Association's Mission: Lifeline Heart Attack Receiving Center Accreditation.

University of California, San Francisco, (UCSF) pharmacy students are being trained to recognize and address unconscious bias in the pharmacy.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Respiratory diseases affect millions worldwide and greatly burden the global health care system financially.

AstraZeneca and Heptares Therapeutics announced that they have entered a licensing agreement which AstraZeneca will acquire exclusive rights to develop the adenosine A2A receptor antagonist, HTL-1071.

Orexigen Therapeutics, Inc. and Takeda Pharmaceutical Company Limited today announced execution of an amended and restated collaboration agreement that resolves all outstanding disputes.

The Academy of Managed Care Pharmacy was included in an Aug. 6 blog entry from The White House Office of National AIDS Policy.

As the 2015 NACDS Total Store Expo nears, the National Association of Chain Drug Stores (NACDS) announces the return of the Online Press Room.

Disagreements between federal lawmakers about Tricare co-payments have delayed the passage of the 2016 National Defense Authorization Act (NDAA).

Bausch and Lomb's Victus femtosecond laser platform has received clearance from the FDA for an enhanced patient interface kit.

Scott A. Meyers, RPh, MS, FASHP, shares his thoughts on pharmacy technicians and their growing role within the pharmacy team.

They say a picture is worth a thousand words, but these pharmacist stock photos leave us with a thousand questions.

A team of researchers from around the country have published findings indicating the accuracy of MSPrecise®, a laboratory test under development for diagnosing MS.

Boston Medical Center has received a $1.3 million grant from the Agency for Healthcare Research and Quality to support a demonstration project of pharmacy-based naloxone rescue kits.

Within a few years of primary prevention defibrillator placement, one-quarter of heart failure (HF) patients show improvements in heart function above the clinical threshold.

Allergan plc and KYTHERA Biopharmaceuticals, Inc. today announced that they have amended and restated their merger agreement with respect to Allergan's pending acquisition of KYTHERA.